Morgan Stanley & Co. LLC has recently announced that it has increased stake in Adicet Bio Inc (NASDAQ:ACET) by 14.23%. After grabbing 2.69 million shares, the institutional investor is now in possession of 0.34 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.24% having worth around $3.18 million. Moreover, The Vanguard Group, Inc. increased its share by 3700.0 to have a control over 1.65 million shares. And FundLogic SASU raised its holdings to 0.98 million shares by acquiring 0.98 million shares or 2.26% of the stake.
Adicet Bio Inc (ACET) concluded trading on 01/04/24 at a closing price of $2.16, with 3.27 million shares of worth about $7.06 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.21% during that period and on Thursday the price saw a gain of about 22.73%. Currently the company’s common shares owned by public are about 42.95M shares, out of which, 30.39M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 31 times over the past 12 months. They bought 1,991,300 shares in 22 of the transactions. In 9 selling transactions, insiders dumped 81,399 shares.
Vanguard Total Stock Market ETF, Candriam Equities L – Oncology Im, and iShares Russell 2000 ETF are the top 3 mutual funds which are holding stakes in Adicet Bio Inc Vanguard Total Stock Market ETF is currently holding 0.94 million shares of worth totaling $1.11 million. The company recently came buying 0.0 shares which brought its stake up to 2.18% of the company’s outstanding shares. iShares Russell 2000 ETF, after buying 0.72 million shares, have now control over 1.67% of the stake in the company. It holds 354.0 shares of worth $0.85 million.
Adicet Bio Inc (NASDAQ: ACET) started trading at $2.00, above $0.24 from concluding price of the previous day. However, the stock later moved at a day high price of 2.3700, or with a gain of 22.73%. Stock saw a price change of 22.73% in past 5 days and over the past one month there was a price change of 74.19%. Year-to-date (YTD), ACET shares are showing a performance of 14.29% which decreased to -74.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.10 but also hit the highest price of $9.52 during that period. The average intraday trading volume for Adicet Bio Inc shares is 407.91K. The stock is currently trading 38.68% above its 20-day simple moving average (SMA20), while that difference is up 56.85% for SMA50 and it goes to -31.47% lower than SMA200.
Morgan Stanley & Co. LLC acquired 2.69 million shares of Adicet Bio Inc having value of about $3.18 million. Data submitted at the U.S SEC by Morgan Stanley & Co. LLC revealed that the firm now holds 0.34 million shares in the company valued at close to $724800.96, or have control over 14.23% stake in the company. Adicet Bio Inc (NASDAQ: ACET) currently have 42.95M outstanding shares and institutions hold larger chunk of about 56.38% of that. Holding of mutual funds in the company is about 22.91% while other institutional holders and individual stake holders have control over 42.64% and 13.93% of the stake respectively.
The stock has a current market capitalization of $93.23M and its 3Y-monthly beta is at 1.93. It has posted earnings per share of -$3.35 in the same period. It has Quick Ratio of 9.40 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACET, volatility over the week remained 13.82% while standing at 11.65% over the month.
Analysts are in expectations that Adicet Bio Inc (ACET) stock would likely to be making an EPS of -$0.71 in the current quarter, while forecast for next quarter EPS is -$0.81 and it is -$2.84 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.78 which is -$0.53 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.72 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -92.85% while it is estimated to increase by 20.14% in next year. EPS is likely to shrink at an annualized rate of 29.10% for next 5-years, compared to annual growth of 50.81% made by the stock over the past 5-years.
Analysts at 9 brokerage firms have issued recommendations for the Adicet Bio Inc (ACET)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.89. Out of those 9 Wall Street analysts, 5 recommended a “Buy” rating, while 4 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
